Renhe Pharmacy announced that its wholly-owned subsidiary Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd. has obtained the "Drug Supplementary Application Approval Notice" for Tadalafil tablets issued by the National Medical Products Administration. Tadalafil is a drug used to treat erectile dysfunction, and the company has previously obtained the drug registration certificate for the 20mg specification. This time, it has added 5mg and 10mg specifications, with a total research and development investment of approximately 5 million yuan.
仁和药业：全资子公司获得他达拉非片药品批件
Renhe Pharmacy: Wholly-owned subsidiary obtains approval for the pharmaceutical of Tadalafil tablets.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated